Abivax publishes its 2025 financial calendar, detailing key financial communications throughout the year. The company is focused on developing therapies for chronic inflammatory diseases ...
R&S Group Holding AG announces increased free float and broadened shareholder base through the sale of shares to Swiss and international investors without lock up restrictions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback